Biotech Crashes 74% After Surprising Liver Failure Sidelines Two Assessments
Biotech inventory Rapt Therapeutics (RAPT) plummeted to a file low Tuesday after the Meals and Drug Management put two of its medical research on cling. X The corporate is trying out a